Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes

Affiliations

Editorial

Gwendolyne Anyanate Jack et al. J Clin Endocrinol Metab. 2023.

. 2023 Sep 18;108(10):e1153-e1154.

doi: 10.1210/clinem/dgad143.

¹ New York Presbyterian-Weill Cornell Medicine, Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism.

No abstract available

Keywords: SGLT2 inhibitors; hyperglycemia; insulin use; type 2 diabetes mellitus.

Comment on

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.
Dagogo-Jack S, Frederich R, Liu J, Cannon CP, Shi H, Cherney DZI, Cosentino F, Masiukiewicz U, Gantz I, Pratley RE. Dagogo-Jack S, et al. J Clin Endocrinol Metab. 2023 Jul 14;108(8):2042-2051. doi: 10.1210/clinem/dgac764. J Clin Endocrinol Metab. 2023. PMID: 36702781 Free PMC article. Clinical Trial.